Shah et al.'s post-hoc analysis of patients enrolled in the randomized, double-blind Treating to New Targets (TNT) trial has revealed that high-dose atorvastatin after CABG surgery reduces the ...
Target LDL-C levels (according to global risk) were attained in 62% of atorvastatin recipients and 6% of bezafibrate recipients, and triglyceride levels <200 mg/dL were achieved in 52% and 60% of ...